Literature DB >> 11000459

Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them.

B A Stocker1.   

Abstract

The development of live bacterial vaccines is reviewed, in particular aromatic-dependent Salmonella, either for protection against the corresponding infections (including typhoid fever) or as carrier-presenter of antigens of unrelated pathogens or of DNA specifying them. Aromatic-dependent Salmonella live vaccines are also compared with BCG and Ty21a and the recent records of exceptional situations are discussed in which aroA (deletion) strains of Salmonella typhimurium cause progressive disease in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000459     DOI: 10.1016/s0168-1656(00)00297-2

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  16 in total

1.  Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system.

Authors:  Kristian Kjaergaard; Henrik Hasman; Mark A Schembri; Per Klemm
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

2.  Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice.

Authors:  C-J Wu; L-C Chen; M-L Kuo
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.

Authors:  Robert L G Rojas; Priscila A D P Gomes; Leticia V Bentancor; Maria E Sbrogio-Almeida; Sérgio O P Costa; Liliana M Massis; Rita C C Ferreira; Marina S Palermo; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Construction of a bivalent DNA vaccine co-expressing S genes of transmissible gastroenteritis virus and porcine epidemic diarrhea virus delivered by attenuated Salmonella typhimurium.

Authors:  Yudi Zhang; Xiaohui Zhang; Xiaodan Liao; Xiaobo Huang; Sanjie Cao; Xintian Wen; Yiping Wen; Rui Wu; Wumei Liu
Journal:  Virus Genes       Date:  2016-03-15       Impact factor: 2.332

5.  Infection of the reproductive tract and eggs with Salmonella enterica serovar pullorum in the chicken is associated with suppression of cellular immunity at sexual maturity.

Authors:  Paul Wigley; Scott D Hulme; Claire Powers; Richard K Beal; Angelo Berchieri; Adrian Smith; Paul Barrow
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Authors:  J Wayne Conlan; Hua Shen; Igor Golovliov; Carl Zingmark; Petra C F Oyston; Wangxue Chen; Robert V House; Anders Sjöstedt
Journal:  Vaccine       Date:  2009-12-16       Impact factor: 3.641

7.  Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine.

Authors:  Yunping Luo; He Zhou; Masato Mizutani; Noriko Mizutani; Ralph A Reisfeld; Rong Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

Review 8.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.

Authors:  Shifeng Wang; Huoying Shi; Yuhua Li; Zhaoxing Shi; Xin Zhang; Chang-Ho Baek; Tabor Mothershead; Roy Curtiss
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

10.  Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.

Authors:  Christofer J Vindurampulle; Stephen R Attridge
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.